Enanta Pharmaceuticals Inc (ENTA): ABBV 1Q25 Mavyret sales=$306M, +5.2% QoQ...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: DewDiligence post# 4076

Friday, 04/25/2025 9:04:55 AM

Friday, April 25, 2025 9:04:55 AM

ABBV 1Q25 Mavyret sales=$306M, +5.2% QoQ, -9.6% YoY in constant currency:

https://investors.abbvie.com/static-files/3f892a1f-9727-4aae-b39d-29f8dd904cb5

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Keep Last Read

Replies (1) Next 10 Prev Next

Go Ad-Free